Weikang Pharmaceutical: The company plans to continue to carry out pharmacodynamic research on the new coronavirus pneumonia, and plans to submit a clinical trial license application to the Center for Drug Evaluation (CDE) of the State Drug Administration by the end of 2022

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002014 002782 300033 300878 Hithink Royalflush Information Network Huangshan Novel Shenzhen Click Technology Zhejiang Wecome Pharmaceutical Research, Development Pharmaceutical Financial, Business Service Epidemic Virus Disease Medicine Traditional Chinese Medicine, Tcm People

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Weikang Pharmaceutical: The company plans to continue to carry out pharmacodynamic research on the new coronavirus pneumonia, and plans to submit a clinical trial license application to the Center for Drug Evaluation (CDE) of the State Drug Administration by the end of 2022